Tradestie Institutional Equity Comparison Engine

FEMY vs PLSE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PLSE Overall Edge

PLSE Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pulse Biosciences, Inc Common Stock (DE) (PLSE) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, FEMY trades at N/M Forward P/E with -763.9% operating margin (-18.9% YoY revenue) versus PLSE at N/M Forward P/E and -5861.2% operating margin (+359.3% YoY). In options structure, FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PLSE sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
FEMY N/M vs PLSE N/M Fwd P/E
Growth & Margin Winner PLSE
Op Margin -763.9% vs -5861.2% ยท YoY -18.9% vs +359.3%
Momentum & Technical Winner PLSE
1Y +54.8% vs +227.9% ยท 52W Pos 17% vs 73%
Options & Structure Winner PLSE
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (10th %ile IV)
FEMY NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap $11.9M
1M Return -22.42%
1Y Return +54.78%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 61.0 Fund 62.0 Flow 50.0 Mom 64.0
PLSE NASDAQ
Pulse Biosciences, Inc Common Stock (DE)
Surgical & Medical Instruments & Apparatus
$46.36
-8.09% 1D
Market Cap $3.7B
1M Return +4.34%
1Y Return +227.86%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 46.0 Flow 70.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FEMY +54.78% PLSE +227.86% Spread: +173.08 pp (PLSE Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period FEMY Revenue PLSE Revenue FEMY Op. Margin PLSE Op. Margin Margin Edge
FY2020 $0M N/A -668.0% N/A FEMY
FY2021 $0M $0M -706.7% -4443.9% FEMY
FY2022 $0M $0M -961.7% -8293.9% FEMY
FY2023 $0M N/A -1353.4% N/A FEMY
FY2024 $0M N/A -1091.8% N/A FEMY
FY2025 $0M $0M -767.0% -21982.6% FEMY

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FEMY (3) vs PLSE (4)
Institutional Metric FEMY PLSE Criterion Row Winner
Market Capitalization Scale $11.9M $3.7B Larger Scale PLSE
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -18.9% +359.3% Higher Growth PLSE
Operating Margin (TTM) Profitability -763.9% -5861.2% Higher Margin FEMY
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -425.0% -60.6% Higher ROE PLSE
52-Week Range Position Momentum 17% ($0โ€“$6) 73% ($13โ€“$59) Stronger Trend PLSE
Beta / 30D Volatility Risk Regime 4.01ฮฒ ยท 72% Vol 1.71ฮฒ ยท 78% Vol Lower Realized Risk FEMY
Unified Institutional Score Composite Signal 52.6 / 100 (HOLD) 40.1 / 100 (SELL) Higher Composite FEMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FEMY vs PLSE Buy Guide
FEMY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PLSE CONSOLIDATION
51d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live PLSE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FEMY nor PLSE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.